Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd.
https://anhearttherapeutics.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd.
Genmab Accelerates Priority Candidates, Ends Enapotamab Vedotin Development
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
- Other Names / Subsidiaries
-
- AnHeart Therapeutics, Co., Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice